Chronic obstructive pulmonary disease after myocardial infarction in the community

American Heart Journal

Volumn 160, Issue 1, 2010, Pages 95-101

  Bursi, Francesca ^a,b   Vassallo, Robert ^a   Weston, Susan A ^a   Killian, Jill M ^a   Roger, Véronique L ^a  

^a MAYO CLINIC   (United States)

^b UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMMUNITY; COMORBIDITY; DEATH; DISEASE ASSOCIATION; FEMALE; HEART INFARCTION; HEART MUSCLE REVASCULARIZATION; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; PATIENT CARE; PREVALENCE; PRIORITY JOURNAL; RESIDENT; RISK FACTOR; SURVIVAL; SURVIVAL RATE;

AGED; FEMALE; HUMANS; INCIDENCE; MALE; MINNESOTA; MYOCARDIAL INFARCTION; ODDS RATIO; PREVALENCE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RESIDENCE CHARACTERISTICS; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL RATE;

EID: 77955687583     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2010.05.004     Document Type: Article

References (33)

1. Barnes P.J. Chronic obstructive pulmonary disease N Engl J Med 343 2000 269 280
2. Pauwels R.A., Buist A.S., and Calverley P.M. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary Am J Respir Crit Care Med. 163 2001 1256 1276
3. Roger V.L., Jacobsen S.J., and Weston S. Trends in the Incidence and Survival of Patients with Hospitalized Myocardial Infarction, Olmsted County, Minnesota, 1979 to 1994 Ann Intern Med 136 2002 341 348
4. Sin D.D., and Man S.F. Why are patients with chronic obstructive pulmonary disease at increased risk of cardiovascular diseases? The potential role of systemic inflammation in chronic obstructive pulmonary disease Circulation 107 2003 1514 1519
5. Doll R., Peto R., and Wheatley K. Mortality in relation to smoking: 40 years' observations on male British doctors BMJ 309 1994 901 911
6. Higgins M.W., Enright P.L., and Kronmal R.A. Smoking and lung function in elderly men and women. The Cardiovascular Health Study JAMA 269 1993 2741 2748
7. Fabbri L.M., and Rabe K.F. From COPD to chronic systemic inflammatory syndrome? Lancet 370 2007 797 799
8. Behar S., Panosh A., and Reicher-Reiss H. Prevalence and prognosis of chronic obstructive pulmonary disease among 5,839 consecutive patients with acute myocardial infarction. SPRINT Study Group Am J Med. 93 1992 637 641
9. Kjoller E., Kober L., and Iversen K. Importance of chronic obstructive pulmonary disease for prognosis and diagnosis of congestive heart failure in patients with acute myocardial infarction Eur J Heart Fail 6 2004 71 77
10. Salisbury A.C., Reid K.J., and Spertus J.A. Impact of chronic obstructive pulmonary disease on post-myocardial infarction outcomes Am J Cardiol 99 2007 636 641
11. Hawkins N.M., Huang Z., and Pieper K.S. Chronic obstructive pulmonary disease is an independent predictor of death but not atherosclerotic events in patients with myocardial infarction: analysis of the Valsartan in Acute Myocardial Infarction Trial (VALIANT) Eur J Heart Fail 11 2009 292 298
12. Steg P.G., Lopez-Sendon J., and Lopez de Sa E. External validity of clinical trials in acute myocardial infarction Arch Intern Med 167 2007 68 73
13. Sin D.D., Wu L., and Man S.F. The relationship between reduced lung function and cardiovascular mortality: a population-based study and a systematic review of the literature Chest 127 2005 1952 1959
14. Anthonisen N.R., Connett J.E., and Kiley J.P. Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1. The Lung Health Study JAMA 272 1994 1497 1505
15. Camilli A.E., Robbins D.R., and Lebowitz M.D. Death certificate reporting of confirmed airways obstructive disease Am J Epidemiol 133 1991 795 800
16. Egred M., Shaw S., and Mohammad B. Under-use of beta-blockers in patients with ischaemic heart disease and concomitant chronic obstructive pulmonary disease QJM 98 2005 493 497
17. Samuels L.E., Kaufman M.S., and Morris R.J. Coronary artery bypass grafting in patients with COPD Chest 113 1998 878 882
18. Melton L.J. III History of the Rochester Epidemiology Project Mayo Clin Proc 71 1996 266 274
19. Roger V.L. Coronary disease surveillance: a public heath imperative Eur Heart J 28 2007 2051 2052
20. Prineas R., Crow R., and Blackburn H. The Minnesota code manual of electrocardiographic findings 1982 John Wright-PSG, Inc. Littleton (MA)
21. Charlson M.E., Pompei P., and Ales K.L. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation J Chronic Dis 40 1987 373 383
22. Damarla M., Celli B.R., and Mullerova H.X. Discrepancy in the use of confirmatory tests in patients hospitalized with the diagnosis of chronic obstructive pulmonary disease or congestive heart failure Respir Care 51 2006 1120 1124
23. Volkova N.B., Kodani A., and Hilario D. Spirometry utilization after hospitalization for patients with chronic obstructive pulmonary disease exacerbations Am J Med Qual 24 2009 61 66
24. Fromer L., and Cooper C.B. A review of the GOLD guidelines for the diagnosis and treatment of patients with COPD Int J Clin Pract 62 2008 1219 1236
25. van der Woude H.J., Zaagsma J., and Postma D.S. Detrimental effects of beta-blockers in COPD: a concern for nonselective beta-blockers Chest 127 2005 818 824
26. Jousilahti P., Vartiainen E., and Tuomilehto J. Symptoms of chronic bronchitis and the risk of coronary disease Lancet 348 1996 567 572
27. Sin D.D., and Man S.F. Chronic obstructive pulmonary disease as a risk factor for cardiovascular morbidity and mortality Proc Am Thorac Soc 2 2005 8 11
28. Bodi V., Sanchis J., and Nunez J. Uncontrolled immune response in acute myocardial infarction: unraveling the thread Am Heart J 156 2008 1065 1073
29. Ross R. Atherosclerosis-an inflammatory disease N Engl J Med 340 1999 115 126
30. Bursi F., Weston S.A., and Killian J.M. C-reactive protein and heart failure after myocardial infarction in the community Am J Med 120 2007 616 622
31. Lindahl B., Toss H., and Siegbahn A. Markers of myocardial damage and inflammation in relation to long-term mortality in unstable coronary artery disease. FRISC Study Group. Fragmin during Instability in Coronary Artery Disease N Engl J Med 343 2000 1139 1147
32. Mancini G.B., Etminan M., and Zhang B. Reduction of morbidity and mortality by statins, angiotensin-converting enzyme inhibitors, and angiotensin receptor blockers in patients with chronic obstructive pulmonary disease J Am Coll Cardiol 47 2006 2554 2560
33. Han M.K., McLaughlin V.V., and Criner G.J. Pulmonary diseases and the heart Circulation 116 2007 2992 3005